Search research articles
Contact Us
Filters
Showing results (191-200 of 256) with videos related to
Page
of 26
Sort By:
The Journal of Urology
|
March 7, 2006
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer
Timothy A Masterson, Fernando J Bianco, Andrew J Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology
|
July 12, 2021
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach
Isamu Tachibana, Adam C Calaway, Zain Abedali, et al.
Occupational and Environmental Medicine
|
July 10, 2025
Maternal occupational exposure to noise: prevalence, maternal effects and infant outcomes in the National Birth Defects Prevention Study, 1997-2011
Kristen W Van Buren, Carissa M Rocheleau, I-Chen Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1997
Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42
E Moran, I Cleary, A M Larkin, et al.
Andrology
|
March 19, 2025
Lost to follow up: Semen analysis compliance following potential vasectomy failure
Max D Sandler, Laura Angulo-Llanos, Rohan Dureja, et al.
Urology
|
March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes
Hristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Sustainability Science
|
August 28, 2018
The undisciplinary journey: early-career perspectives in sustainability science
L Jamila Haider, Jonas Hentati-Sundberg, Matteo Giusti, et al.
Page
of 26
Search research articles
Search
Showing results (191-200 of 256) with videos related to
Sort By:
Page
of 26
The Journal of Urology
|
March 7, 2006
The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer
Timothy A Masterson, Fernando J Bianco, Andrew J Vickers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2022
Primary Retroperitoneal Lymph Node Dissection for Patients With Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
Urologic Oncology
|
July 12, 2021
Definitive surgical therapy for refractory radiation cystitis: Evaluating effectiveness, tolerability, and extent of surgical approach
Isamu Tachibana, Adam C Calaway, Zain Abedali, et al.
Occupational and Environmental Medicine
|
July 10, 2025
Maternal occupational exposure to noise: prevalence, maternal effects and infant outcomes in the National Birth Defects Prevention Study, 1997-2011
Kristen W Van Buren, Carissa M Rocheleau, I-Chen Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 6, 2020
Prognostic Value of Teratoma in Primary Tumor and Postchemotherapy Retroperitoneal Lymph Node Dissection Specimens in Patients With Metastatic Germ Cell Tumor
Fadi Taza, Michal Chovanec, Anna Snavely, et al.
European Urology
|
October 4, 2022
Reply to Alireza Ghoreifi and Hooman Djaladat's Letter to the Editor re: Isamu Tachibana, Sean Q. Kern, Antoin Douglawi, et al. Primary Retroperitoneal Lymph Node Dissection for Patients with Pathologic Stage II Nonseminomatous Germ Cell Tumor-N1, N2, and N3 Disease: Is Adjuvant Chemotherapy Necessary? J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00118: Is Retroperitoneal Lymph Node Dissection Without Adjuvant Chemotherapy Enough for All Patients with Pathologic Stage II Nonseminoma Germ Cell Tumor?
Isamu Tachibana, Sean Q Kern, Antoin Douglawi, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 1997
Co-expression of MDR-associated markers, including P-170, MRP and LRP and cytoskeletal proteins, in three resistant variants of the human ovarian carcinoma cell line, OAW42
E Moran, I Cleary, A M Larkin, et al.
Andrology
|
March 19, 2025
Lost to follow up: Semen analysis compliance following potential vasectomy failure
Max D Sandler, Laura Angulo-Llanos, Rohan Dureja, et al.
Urology
|
March 4, 2014
Plasmacytoid bladder cancer: variant histology with aggressive behavior and a new mode of invasion along fascial planes
Hristos Z Kaimakliotis, M Francesca Monn, Liang Cheng, et al.
Sustainability Science
|
August 28, 2018
The undisciplinary journey: early-career perspectives in sustainability science
L Jamila Haider, Jonas Hentati-Sundberg, Matteo Giusti, et al.
Page
of 26